Retour à l'index des publications
Export 34 results:
Warning on RTF export
×
If you export in RTF and open your file with microsoft Word, you need to choose "Occidental (Windows Latin 1)" encoding.

Journal Article

  1. [BERE-14]S. Beretta, Cuccione, E., Versace, A., Carone, D., Riva, M., Padovano, G., Dell'Era, V., Cai, R., Monza, L., Presotto, L., Rousseau, D., Chauveau, F., Paterno, G., Pappada, G., Giussani, C., Sganzeria, E., and Ferrarese, C., “Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke”, Neurobiology of disease, 2014.
  2. [DURA-14]A. Durand, Chauveau, F., Cho, T. H., Kallus, C., Wagner, M., Boutitie, F., Maucort-Boulch, D., Berthezène, Y., Wiart, M., and Nighoghossian, N., “Effects of a TAFI-Inhibitor Combined with a Suboptimal Dose of rtPA in a Murine Thromboembolic Model of Stroke”, Cerebrovascular Diseases, vol. 38, pp. 268-275, 2014.
  3. [MARI-13b]M. Marinescu, Langer, M., Durand, A., Olivier, C., Chabrol, A., Rositi, H., Chauveau, F., Cho, T. H., Nighoghossian, N., Berthezène, Y., Peyrin, F., and Wiart, M., “Synchrotron Radiation Micro-Computed Tomography as a new method to detect iron oxide nanoparticles in the brain”, Molecular Imaging in Biology, vol. (in press), 2013.
  4. [MARI-13a]M. Marinescu, Chauveau, F., Durand, A., Riou, A., Cho, T. H., Dencausse, A., Ballet, S., Nighoghossian, N., Berthezène, Y., and Wiart, M., “Monitoring therapeutic effects in experimental stroke by serial USPIO-enhanced MRI”, European Radiology, vol. 23, pp. 37-47, 2013.
  5. [RIOU-13]A. Riou, Chauveau, F., Cho, T. H., Marinescu, M., Nataf, S., Nighoghossian, N., Berthezène, Y., and Wiart, M., “MRI assessment of intra-carotid route for macrophage delivery after transient cerebral ischemia”, NMR Biomed, vol. 26, pp. 115-123, 2013.
  6. [DESE-13]V. Desestret, Riou, A., Chauveau, F., Cho, T. H., Devillard, E., Marinescu, M., Ferrera, R., Rey, C., Chanal, M., Angoulvant, D., Honnorat, J., Nighoghossian, N., Berthezène, Y., Nataf, S., and Wiart, M., “In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages”, PLoS One, vol. 8, 2013.
  7. [CHO-13]T. H. Cho, Aguettaz, P., Campuzano Larrea, O., Charriaut-Marlangue, C., Riou, A., Berthezène, Y., Nighoghossian, N., Ovize, M., Wiart, M., and Chauveau, F., “Pre- and post-treatment with cyclosporine A in a rat model of transient focal cerebral ischaemia with multimodal MRI screening”, International Journal of Stroke, vol. 8, pp. 669-674, 2013.
  8. [CHAU-12a]F. Chauveau, Cho, T. H., Riou, A., Langlois, J. B., Berthezène, Y., Nighoghossian, N., and Wiart, M., “Does acute behavioral testing reflect successful ischemia in rats with transient middle cerebral artery occlusion?”, International Journal of Stroke, vol. 7, pp. 465-472, 2012.
    http://www.ncbi.nlm.nih.gov/pubmed/22151768
  9. [DURA-12]A. Durand, Chauveau, F., Cho, T. H., Bolbos, R., Langlois, J. B., Hermitte, L., Wiart, M., Berthezène, Y., and Nighoghossian, N., “Spontaneous reperfusion after in situ thromboembolic stroke in mice”, Plos One, vol. 7, p. e50083, 2012.
  10. [BRIS-11]J. C. Brisset, Sigovan, M., Chauveau, F., Riou, A., Devillard, E., Desestret, V., Touret, M., Nataf, S., Honnorat, J., Canet-Soulas, E., Nighoghossian, N., Berthezène, Y., and Wiart, M., “Quantification of iron-labeled cells with positive contrast in mouse brains”, Molecular Imaging and Biology, vol. 13, pp. 672-678, 2011.
    http://www.ncbi.nlm.nih.gov/pubmed/20734153
  11. [CHAU-11a]F. Chauveau, Cho, T. H., Perez, M., Guichardant, M., Riou, A., Aguettaz, P., Picq, M., Lagarde, M., Berthezène, Y., Nighoghossian, N., and Wiart, M., “Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact”, Curr Neurovasc Res, vol. 8, pp. 95-102, 2011.
    http://www.ncbi.nlm.nih.gov/pubmed/21443458
  12. [CHAU-10a]F. Chauveau, Moucharrafie, S., Wiart, M., Brisset, J. C., Berthezène, Y., Nighoghossian, N., and Cho, T. H., “In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure”, Experimental and Translational Stroke Medicine, vol. 2, p. 4, 2010.
  13. [BRIS-10a]J. C. Brisset, Desestret, V., Devillard, E., Marcellino, S., Chauveau, F., Lagarde, F., Nataf, S., Honnorat, J., Nighoghossian, N., Berthezène, Y., and Wiart, M., “Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7T and 7T”, Eur Radiol, vol. 20, pp. 275-285, 2010.
  14. [CHAU-10b]F. Chauveau, Cho, T. H., Berthezène, Y., Nighoghossian, N., and Wiart, M., “Imaging inflammation in stroke using magnetic resonance imaging”, Int J Clin Pharm Th, vol. 48, pp. 718-728, 2010.
    http://www.ncbi.nlm.nih.gov/pubmed/20979930

Conference Paper

  1. [ROSI-15]H. Rositi, Desestret, V., Chauveau, F., Cho, T. H., Ong, E., Berner, L. P., Weber, L., Langer, M., Olivier, C., Frindel, C., Nighoghossian, N., Berthezène, Y., Peyrin, F., Rousseau, D., and Wiart, M., “Fast virtual histology of unstained mouse brains using in-line X-ray phase tomography”, in European Molecular Imaging Meeting, Tubingen, Germany, 2015.
  2. [45676]E. Ong, Vadcard, F., Verdurand, M., Rositi, H., Peyrin, F., Berthezène, Y., Nighoghossian, N., Lerouge, F., Parola, S., Zimmer, L., Wiart, M., and Chauveau, F., “In vivo evaluation of a hybrid nanoparticle for molecular imaging of amyloid aggregation”, in European Molecular Imaging Meeting, Tubingen, Germany, 2015.
  3. [BERN-14]L. P. Berner, Vadcard, F., Rositi, H., Chauveau, F., Cho, T. H., Ong, E., Durand, A., Nighoghossian, N., Berthezène, Y., Parola, S., and Wiart, M., “Investigation of a fluorescent magnetic hybrid nanoprobe for stroke imaging”, in European Molecular Imaging Meeting, 2014.
  4. [FRIN-13a]C. Frindel, Rositi, H., Sdika, M., Chauveau, F., Cho, T. H., Neyran, B., Rousseau, D., Wiart, M., Berthezène, Y., and Nighoghossian, N., “Démonstrateur en imagerie à vocation diagnostique dans le cadre de l’AVC”, in 4ème Journée Démonstrateurs, Angers, France, 2013.
  5. [DAUD-13]H. Daudet, Collomb, A., Frindel, C., Chauveau, F., Wiart, M., Berthezène, Y., and Nighoghossian, N., “Comparison of different normalization strategies in cerebral perfusion MRI”, in European Society for Magnetic Resonance in Medicine and Biology (ESMRMB), Toulouse (France), 2013, pp. 3-5 october.
  6. [TAMI-13]A. Tamion, Maraloiu, V. A., Chauveau, F., Rositi, H., Hillion, A., Hillenkamp, M., Blanchin, M. G., Wiart, M., and Dupuis, V., “Biodegradability of superparamagnetic nanoparticles of iron oxide used as MRI contrast agents in organic tissue and intra-cellular environments”, in European Material Research Society (EMRS), Strasbourg (France), 2013.
  7. [MARI-12]M. Marinescu, Langer, M., Durand, A., Olivier, C., Chabrol, A., Rositi, H., Chauveau, F., Cho, T. H., Nighoghossian, N., Peyrin, F., Wiart, M., and Berthezène, Y., “Synchrotron Radiation Micro-Computed Tomography as a new method to detect iron oxide nanoparticles in the brain”, in Radiological Society of North America (RSNA), Chicago, Michigan, USA, 2012.
  8. [CHAU-11a]F. Chauveau, Cho, T. H., Perez, M., Guichardant, M., Riou, A., Aguettaz, P., Picq, M., Lagarde, M., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI evaluation of the neuroprotective effect of a brain-targeting form of docosahexaenoic acid after stroke”, in International Stroke Conference, Los Angeles, California, USA, 2011, p. e216.
  9. [MARI-11a]M. Marinescu, Durand, A., Riou, A., Chauveau, F., Nighoghossian, N., Wiart, M., and Berthezène, Y., “Monitoring minocycline therapy in stroke-induced mice using MRI coupled with intravenous USPIO administration”, in World Molecular Imaging Congress, San Diego, California, USA, 2011.
  10. [DURA-11]A. Durand, Chauveau, F., Lhermitte, L., Cho, T. H., Berthezène, Y., Nighoghossian, N., and Wiart, M., “Acute MRI characterization of in situ thromboembolic stroke in mice”, in World Molecular Imaging Congress, San Diego, California, USA, 2011.
  11. [RIOU-11]A. Riou, Chauveau, F., Cho, T. H., Marinescu, M., Nataf, S., Rémy, C., Barbier, E., Nighoghossian, N., Wiart, M., and Berthezène, Y., “Treatment with bone marrow-derived alternatively activated (M2) macrophages after transient ischemia: A USPIO-Enhanced longitudinal MRI study in rats”, in World Molecular Imaging Congress, San Diego, California, USA, 2011.
  12. [BRIS-10c]J. C. Brisset, Sigovan, M., Chauveau, F., Riou, A., Nighoghossian, N., Berthezène, Y., and Wiart, M., “Relaxometry vs artifact volume for estimating the number of iron-labeled macrophages: in vivo testing in the mouse brain”, in International Society for Magnetic Resonance in Medicine, Stockholm, Sweden, 2010.
  13. [CHAU-10c]F. Chauveau, Cho, T. H., Riou, A., Aguettaz, P., Picq, M., Lagarde, M., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI evaluation of the neuroprotective effect of a brain-targeting form of docosahexaenoic acid after stroke”, in World Molecular Imaging Congress, Kyoto, Japan, 2010.
  14. [RIOU-10b]A. Riou, Chauveau, F., Cho, T. H., Marinescu, M., Nataf, S., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI monitoring of intra-arterial delivery of bone marrow-derived macrophages after transient ischemia”, in World Molecular Imaging Congress, Kyoto, Japan, 2010.
  15. [RIOU-10a]A. Riou, Chauveau, F., Cho, T. H., Marinescu, M., Nataf, S., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI study of intra-arterial bone marrow-derived macrophage administration after acute focal ischemic stroke in rats”, in 5th European Molecular Imaging Meeting, Warsaw, Poland, 2010.
  16. [CHO-10a]T. H. Cho, Chauveau, F., Riou, A., Langlois, J. B., Berthezène, Y., Nighoghossian, N., and Wiart, M., “Multiparametric MRI at the acute stage of ischemic stroke: improved subject selection for preclinical trials of neuroprotective drugs”, in World Molecular Imaging Congress, Kyoto, Japan, 2010.
  17. [CHAU-09b]F. Chauveau, Cho, T. H., Riou, A., Picq, M., Lagarde, M., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI evaluation of the neuroprotective effect of docosahexanoic acid after stroke”, in World Molecular Imaging Congress, Montreal, Canada, 2009.
  18. [BRIS-09a]J. C. Brisset, Desestret, V., Marcellino, S., Devillard, E., Chauveau, F., Lagarde, F., Nataf, S., Nighoghossian, N., Berthezène, Y., and Wiart, M., “In vivo assessment of the number of iron-labeled cells using T2 quantification”, in International Society for Magnetic Resonance in Medicine, Honolulu, Hawaii, USA, 2009.
  19. [CHAU-09a]F. Chauveau, Cho, T. H., Riou, A., Picq, M., Lagarde, M., Berthezène, Y., Nighoghossian, N., and Wiart, M., “MRI evaluation of the neuroprotective effect of docosahexanoic acid after stroke”, in 26nd Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Antalya, Turkey, 2009.

Book Chapter

  1. [CHAU-12]F. Chauveau, Marinescu, M., Cho, T. H., Wiart, M., Berthezène, Y., and Nighoghossian, N., “MRI assessment of post-ischemic neuroinflammation and neuroprotection in ischemic stroke models and prediction of stroke severity in patients”, in Neuroimaging - Methods, InTechs 2012.